(Q44460275)

English

One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial

scientific article published in April 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial (English)

1 reference

Europe PubMed Central

3 December 2017

1 reference

based on heuristic

inferred from title

1

object named as

Califf RM

1 reference

Europe PubMed Central

3 December 2017

2

object named as

Topol EJ

1 reference

Europe PubMed Central

3 December 2017

Dean J Kereiakes

4

object named as

Kereiakes DJ

1 reference

Europe PubMed Central

3 December 2017

3

object named as

George BS

1 reference

Europe PubMed Central

3 December 2017

Charles W. Abbottsmith

9

object named as

Abbottsmith C

1 reference

Europe PubMed Central

3 December 2017

author name string

Aronson LG

5

1 reference

Europe PubMed Central

3 December 2017

Lee KL

6

1 reference

Europe PubMed Central

3 December 2017

Martin L

7

1 reference

Europe PubMed Central

3 December 2017

Candela R

8

1 reference

Europe PubMed Central

3 December 2017

O'Neill WW

10

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 April 1990

1 reference

Europe PubMed Central

3 December 2017

American Heart Journal

1 reference

Europe PubMed Central

3 December 2017

119

1 reference

Europe PubMed Central

3 December 2017

4

1 reference

Europe PubMed Central

3 December 2017

777-785

1 reference

Europe PubMed Central

3 December 2017

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Risk stratification and survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Prognosis after initial myocardial infarction: The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Coronary anatomy and prognosis after myocardial infarction in patients 60 years of age and younger

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

A cost-effectiveness model for coronary thrombolysis/reperfusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Nonfatal cardiac events and recurrent infarction in the year after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Hospital Discharge One Week after Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Administration of thrombolytic therapy in the community hospital: established principles and unresolved issues

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980311-4

7 January 2021

Identifiers

10.1016/S0002-8703(05)80311-4

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44460275&oldid=2024778887"